We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
Cap. Flow
+$5.08B
Cap. Flow %
14.42%
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$410M
2
SNAP icon
Snap
SNAP
+$321M
3
MO icon
Altria Group
MO
+$312M
4
META icon
Meta Platforms (Facebook)
META
+$295M
5
INTC icon
Intel
INTC
+$283M

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$407M
2
ABBV icon
AbbVie
ABBV
+$283M
3
SPGI icon
S&P Global
SPGI
+$251M
4
AMZN icon
Amazon
AMZN
+$221M
5
LLY icon
Eli Lilly
LLY
+$197M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 18.6%
3 Financials 10.47%
4 Industrials 10.2%
5 Consumer Discretionary 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WORX
2601
DELISTED
SCWORX CORP NEW
WORX
$7K ﹤0.01%
47
-5
-10% -$954
ACOR
2602
DELISTED
Acorda Therapeutics
ACOR
$7K ﹤0.01%
720
UPH
2603
DELISTED
UpHealth, Inc.
UPH
$7K ﹤0.01%
+1,130
New +$8.79K
SNES icon
2604
SenesTech
SNES
$7.21M
$6K ﹤0.01%
5
LMNL
2605
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$6K ﹤0.01%
1,080
EMBK
2606
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$6K ﹤0.01%
+600
New +$35K
CPHI icon
2607
China Pharma Holdings
CPHI
$49M
$5K ﹤0.01%
47
-9
-16% -$1.2K
DSS icon
2608
DSS Inc
DSS
$5.61M
$5K ﹤0.01%
732
-313
-30% -$2.49K
SINT icon
2609
SiNtx Technologies
SINT
$9.09M
$5K ﹤0.01%
1
AUMN
2610
DELISTED
Golden Minerals Company
AUMN
$5K ﹤0.01%
592
FNHC
2611
DELISTED
FedNat Holding Company Common Stock
FNHC
$5K ﹤0.01%
14,600
-1,600
-10% -$874
MF
2612
DELISTED
Missfresh Limited American Depositary Shares
MF
$5K ﹤0.01%
+600
New +$9.39K
MITO
2613
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$4K ﹤0.01%
15,400
-1,000
-6% -$344
ABEO icon
2614
Abeona Therapeutics
ABEO
$349M
$3K ﹤0.01%
552
-1,028
-65% -$5.2K
CSCI
2615
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$3K ﹤0.01%
157
-228
-59% -$5.71K
GPL
2616
DELISTED
Great Panther Mining Limited
GPL
$3K ﹤0.01%
2,230
-2,890
-56% -$5.47K
ENVB icon
2617
Enveric Biosciences
ENVB
$5.32M
$2K ﹤0.01%
+1
New +$2.13K
DBGI
2618
Digital Brands Group
DBGI
$5.53M
0
ENJY
2619
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$2K ﹤0.01%
+11,500
New +$13.4K
ABEV icon
2620
Ambev
ABEV
$47B
-10,700
Closed -$35K
ABM icon
2621
ABM Industries
ABM
$2.85B
-9,500
Closed -$437K
ACGL icon
2622
Arch Capital
ACGL
$36.5B
-11,200
Closed -$542K
ACHC icon
2623
Acadia Healthcare
ACHC
$3.06B
-14,200
Closed -$931K
ACHV icon
2624
Achieve Life Sciences
ACHV
$629M
-12,485
Closed -$95K
ACIU icon
2625
AC Immune
ACIU
$229M
-23,644
Closed -$95K

Similar funds

Two Sigma Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.

  • Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
  • Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
  • Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
  • Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
  • Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
  • Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
  • Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.